Access to experimental monkeypox treatment remains uneven, doctors say
By Neeraj G. Patel and Nadia Kounang, CNN A drug is available for monkeypox patients who have or who are at risk of severe disease, but doctors say they continue to face challenges getting access to it. The US Food and Drug Administration hasn’t approved tecovirimat — sold under the brand name Tpoxx — specifically
Continue Reading